A. Mastrangeli

发表

Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH

R. Crystal, G. Wolff, M. Gershengorn, 1996, Nature Genetics.

Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung.

R. Crystal, K. Holroyd, R. Buhl, 1991, The Journal of clinical investigation.

Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine.

C. Henschke, D. Yankelevitz, N. Kemeny, 1997, Human gene therapy.

Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum.

D. Ingram, S. Kato, G. Roth, 1995, Brain research. Molecular brain research.

A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.

S. Brody, C. Chu, J. Hay, 1995, Human gene therapy.

Activation of alveolar macrophages in asymptomatic HIV-infected individuals.

R. Crystal, K. Holroyd, R. Buhl, 1993, Journal of immunology.

Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands.

R. Crystal, B. Baum, B. O'Connell, 1996, Human gene therapy.

Direct in vivo adenovirus-mediated gene transfer to salivary glands.

R. Crystal, B. Baum, B. O'Connell, 1994, The American journal of physiology.

Gene therapy for the respiratory manifestations of cystic fibrosis.

S. Brody, C. Chu, N. Eissa, 1995, American journal of respiratory and critical care medicine.

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

R. Crystal, S. Brody, C. Chu, 1994, Nature Genetics.

Construction of an adenovirus type 7a E1A- vector

D. Brough, R. Crystal, E. Falck-Pedersen, 1997, Journal of virology.

SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS

R. Crystal, K. Holroyd, A. Cantin, 1989, The Lancet.

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.

R. Crystal, N. Hackett, B. Harvey, 1997, Human gene therapy.

Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.

M. Perricaudet, R. Crystal, C. Danel, 1993, The Journal of clinical investigation.

In vivo adenovirus-mediated gene transfer to lungs via pulmonary artery.

R. Crystal, C. Danel, P. Lemarchand, 1994, Journal of applied physiology.

Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors

Sanford H. Feldman, Ronald G. Crystal, R. Crystal, 1993, Nature Genetics.

Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studies

D. Ingram, R. Crystal, A. Mastrangeli, 1995, Brain Research.

Glutathione deficiency and HIV

R. Crystal, K. Holroyd, R. Buhl, 1990, The Lancet.

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.

B. Harvey, G. Wolff, R. Crystal, 1996, Human gene therapy.

Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.

C. Henschke, B. Harvey, R. Crystal, 1995, Human gene therapy.